$0.0900
+0.0120 (+15.38%)
At Close: Jun 23, 2026
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
08:27am, Thursday, 27'th Mar 2025
GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today a
ProPhase Labs to Present at the Investor Summit Virtual on March 11
08:00am, Friday, 07'th Mar 2025
GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today
Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now
10:56am, Wednesday, 05'th Mar 2025
ProPhase Labs (PRPH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
08:00am, Wednesday, 26'th Feb 2025
New York, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase La
Company Announces Ongoing Strategic Cost Cutting to Focus Resources on new DTC Marketing Initiatives to Drive Growth and Profitability Dispels rumors of an Investment Bank initiating a Capital Raise G
Company Actively Pursuing Strategic Alternatives Including the Potential Sale of Nebula Genomics and DNA Complete to Unlock Immediate Cash GARDEN CITY, NY, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ProPhase L
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
08:00am, Tuesday, 18'th Feb 2025
GARDEN CITY, NY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today a
ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript
02:49pm, Friday, 15'th Nov 2024
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q3 2024 Results Conference Call November 13, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Execu
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates
10:15am, Wednesday, 13'th Nov 2024
ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago.
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
09:52am, Monday, 11'th Nov 2024
GARDEN CITY, NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and diagnostics company, today announce
ProPhase Labs Announces Pricing of Public Offering of Common Stock
11:37pm, Thursday, 07'th Nov 2024
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announce
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025
08:00am, Thursday, 17'th Oct 2024
Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
08:00am, Tuesday, 27'th Aug 2024
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NA
ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
11:10am, Monday, 19'th Aug 2024
GARDEN CITY, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today announc
ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript
03:03pm, Wednesday, 14'th Aug 2024
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2024 Earnings Conference Call August 14, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Execut
Sign In
Buy PRPH